Table 3

Summary HIP (percentage) incidence and population insulin sensitivity (KxgI) statistics for baseline and scaling up and scaling back scenarios simulated from 2018 to 2060

HIP incidence (%)	2020			2030			2040			2050			2060
HIP incidence (%)	%	95% CI (±)	% change from baseline	%	95% CI (±)	% change from baseline	%	95% CI (±)	% change from baseline	%	95% CI (±)	% change from baseline	%	95% CI (±)	% change from baseline
Baseline	15.6	0.28		15.8	0.31		16.9	0.31		17.2	0.3		17.0	0.3
Scenario A: all normal weight	15.9	0.26	1.8	15.9	0.31	0.8	17.1	0.31	1.4	17.0	0.3	−0.9	13.4*	0.3	−21.2
Scenario B: more overweight or obese	15.7	0.27	0.4	15.7	0.30	−0.6	17.1	0.27	1.3	17.3	0.3	0.4	17.6	0.3	3.8

Insulin sensitivity (KxgI)	2020			2030			2040			2050			2060
Insulin sensitivity (KxgI)	Mean	95% CI (±)	% change from baseline	Mean	95% CI (±)	% change from baseline	Mean	95% CI (±)	% change from baseline	Mean	95% CI (±)	% change from baseline	Mean	95% CI (±)	% change from baseline
Baseline	50.3	0.02		48.4	0.02		46.4	0.03		45.7	0.02		45.6	0.02
Scenario A: all normal weight	50.9	0.02	1.2	52.5	0.02	8.5	54.2	0.03	16.9	60.0	0.03	31.2	67.1	0.04	47.3
Scenario B: more overweight or obese	49.7	0.02	−1.2	44.6	0.02	−7.8	39.3	0.02	−15.4	34.7	0.02	−24.1	31.5	0.02	−30.9

KxgI: an index of insulin sensitivity representing insulin-dependent glucose tissue reuptake.
*Significantly different from baseline at p<0.05.
HIP, hyperglycemia in pregnancy.